Kaberi Dasgupta, a professor of medicine at McGill University and a researcher, says this would be good news for people who have excess weight and resulting complications but who can't currently afford the branded medications
1 In fact, the impact of GLP-1s is likely to be more nuanced than the blunt conclusions drawn by market watchers, with some companies and segments affected more than others
Chen JK, Merrick KA, Kong YW, Izrael-Tomasevic A, Eng G, Handly ED et al (2024) An RNA damage response network mediates the lethality of 5-FU in colorectal cancer
Reclamation looks different to everyone
Until more research is conducted, he says patients should be aware of this information and, in consultation with their care team, make a careful, informed choice based on their individual risk profile. The AAOph and the North American Neuro-Ophthalmology Society offered several other comments and concerns regarding the design and limitations of the study